Inflammatory Bowel Disease Journal Articles

• Genetic Factors in Sofosbuvir Treatment for Chronic HCV Are there patient-specific genetic factors that might help predict HCV patients likely to fail sofosbuvir treatment?
  Liver International, May 23, 2022
• Emerging Drug Therapies in Inflammatory Bowel Disease Several new IBD drug therapies are currently in early clinical trials, with more in the therapeutic pipeline. Review the latest data in this article.
  Alimentary Pharmacology & Therapeutics, May 18, 2022
• Use of IBD Services During the COVID-19 Pandemic How did the COVID-19 pandemic impact emergency and elective services for inflammatory bowel disease?
  Alimentary Pharmacology & Therapeutics, May 11, 2022
• Risk of Herpesvirus and Serious Infections in Atopic Dermatitis This study suggests that atopic dermatitis is associated with an increased risk of hospital admission with infections, opportunistic infections and herpesvirus infections in both children and adults.
  The British Journal of Dermatology, May 10, 2022
• Ustekinumab Levels in Pregnant Women With IBD This study details the pharmacokinetics of ustekinumab in women with IBD who received the drug during pregnancy as well as in infants exposed in utero.
  Alimentary Pharmacology & Therapeutics, April 20, 2022
• Third mRNA Vaccine in Preventing COVID-19 Hospitalization According to this CDC report, a third dose of an mRNA COVID-19 vaccine significantly increases effectiveness against hospitalization among adults without and with immunocompromising conditions.
  Morbidity & Mortality Weekly Report, April 18, 2022
• Progression in IBD With Indefinite and Low-grade Dysplasia What is the incidence of and risk factors for advanced neoplasia in inflammatory bowel disease patients with indefinite and low-grade dysplasia?
  Alimentary Pharmacology & Therapeutics, April 13, 2022
• Immunosuppressive Drugs and COVID-19 Severity in AIH This study found that patients with autoimmune hepatitis who were taking certain immunosuppressants prior to the onset of COVID-19 had more severe courses of COVID-19.
  Liver International, April 11, 2022
• Bowel Ultrasound Assesses Response to Therapy in Crohn's Disease The authors developed a non-invasive bowel ultrasound score to assess disease activity in Crohn's disease.
  Alimentary Pharmacology & Therapeutics, March 15, 2022
• Ustekinumab or Vedolizumab in Patient's With Crohn's Disease This study indicates that in patients with Crohn's disease refractory to anti-TNF, ustekinumab is more effective than vedolizumab as maintenance treatment.
  Alimentary Pharmacology & Therapeutics, March 10, 2022
• Safety and Efficacy of Tofacitinib for Ulcerative Colitis This paper presents final data from OCTAVE Open, an open-label, long-term extension study on the safety and efficacy of the Janus kinase inhibitor tofacitinib for the treatment of ulcerative colitis.
  Alimentary Pharmacology & Therapeutics, March 08, 2022
• Use of Contraceptives and Risk of Inflammatory Bowel Disease How might different types, dose, and duration of hormonal contraceptives impact the risk of developing inflammatory bowel disease?
  Alimentary Pharmacology & Therapeutics, March 01, 2022
• Safety of Recombinant Zoster Vaccine in Rheumatology Patients Is the recombinant zoster vaccine safe to use in rheumatology patients taking immunosuppressive medications?
  Southern Medical Journal, February 23, 2022
• Risk Factors of IBD in Eastern vs. Western Populations Do environmental and dietary risk factors for IBD differ between Eastern and Western populations?
  Alimentary Pharmacology & Therapeutics, February 22, 2022
• Should High-fiber Diets Be Recommended for Patients With IBD? Patients with IBD are often intolerant of dietary fiber and have been counseled to avoid it, but emerging evidence suggests that increased dietary fiber intake may be both tolerable and beneficial.
  Current Opinion in Gastroenterology, February 21, 2022
• Incidence, Outcomes, and Impact of COVID-19 on IBD Does inflammatory bowel disease increase the risk of contracting COVID-19? In what ways might IBD impact the course of COVID-19?
  Alimentary Pharmacology & Therapeutics, February 08, 2022
• Psoriasis-related Treatment, Hospitalization Due to COVID-19 Have systemic treatments for psoriasis been associated with an increased risk of hospitalization or in-hospital mortality due to COVID-19?
  The British Journal of Dermatology, February 07, 2022
• The Impact of IBD Medications on Risk of Pneumonia This study aimed to determine the incidence of pneumonia and pneumonia-related hospitalization in persons with IBD, and the impact IBD medications might have on such outcomes.
  Alimentary Pharmacology & Therapeutics, February 03, 2022
• Association Between Circulating Bile Acid Alterations and NASH This study aimed to elucidate alterations in bile acid metabolism according to NAFLD severity, in the absence of obesity.
  Liver International, January 31, 2022
• Carbapenem-Resistant P aeruginosa and Medical Tourism Cases of infection with carbapenem-resistant P. aeruginosa were traced back to US medical tourists who underwent surgical procedures in Mexico.
  Emerging Infectious Diseases, January 28, 2022